Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

Palliative chemotherapy

  • You have access
    Initiation of Systemic Therapy During the Last 30 Days of Life in Patients With Metastatic Castration-resistant Prostate Cancer
    CARSTEN NIEDER, ELLINOR HAUKLAND, BÅRD MANNSÅKER, ADAM PAWINSKI, ROSALBA YOBUTA and JAN NORUM
    Anticancer Research January 2019, 39 (1) 335-340; DOI: https://doi.org/10.21873/anticanres.13116
  • You have access
    Expression of Estrogen Receptor-α and Survival in Advanced-stage Non-small Cell Lung Cancer
    MARIUS LUND-IVERSEN, HELGE SCOTT, ERIK H. STRØM, NOAH THEISS, ODD TERJE BRUSTUGUN and BJØRN H. GRØNBERG
    Anticancer Research April 2018, 38 (4) 2261-2269;
  • You have access
    Cancer Treatment of Severely-III Patients Not Eligible for Chemotherapy
    MARGARETA RANDÉN, SARA RUNESDOTTER and PETER STRANG
    Anticancer Research December 2013, 33 (12) 5639-5643;
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire